Tags

Type your tag names separated by a space and hit enter

Is TNF inhibitor exposure a risk factor for amyotrophic lateral sclerosis?
Fundam Clin Pharmacol 2019; 33(6):687-688FC

Authors+Show Affiliations

1st Department of Neurology, School of Medicine, Eginition Hospital, National and Kapodistrian University of Athens, Vassilisis Sophias Avenue 72-74, 11528, Athens, Greece.

Pub Type(s)

Editorial

Language

eng

PubMed ID

31618791

Citation

Bougea, Anastasia. "Is TNF Inhibitor Exposure a Risk Factor for Amyotrophic Lateral Sclerosis?" Fundamental & Clinical Pharmacology, vol. 33, no. 6, 2019, pp. 687-688.
Bougea A. Is TNF inhibitor exposure a risk factor for amyotrophic lateral sclerosis? Fundam Clin Pharmacol. 2019;33(6):687-688.
Bougea, A. (2019). Is TNF inhibitor exposure a risk factor for amyotrophic lateral sclerosis? Fundamental & Clinical Pharmacology, 33(6), pp. 687-688. doi:10.1111/fcp.12513.
Bougea A. Is TNF Inhibitor Exposure a Risk Factor for Amyotrophic Lateral Sclerosis. Fundam Clin Pharmacol. 2019;33(6):687-688. PubMed PMID: 31618791.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Is TNF inhibitor exposure a risk factor for amyotrophic lateral sclerosis? A1 - Bougea,Anastasia, PY - 2019/10/17/pubmed PY - 2019/10/17/medline PY - 2019/10/17/entrez SP - 687 EP - 688 JF - Fundamental & clinical pharmacology JO - Fundam Clin Pharmacol VL - 33 IS - 6 SN - 1472-8206 UR - https://www.unboundmedicine.com/medline/citation/31618791/Is_TNF_Inhibitor_Exposure_a_Risk_Factor_for_Amyotrophic_Lateral_Sclerosis L2 - https://doi.org/10.1111/fcp.12513 DB - PRIME DP - Unbound Medicine ER -
Unbound Prime app for iOS iPhone iPadUnbound PubMed app for AndroidAlso Available:
Unbound MEDLINE
Unbound PubMed app for Windows